Improving the solubility of poorly soluble APIs remains one of the biggest challenges for pharmaceutical companies. Not to mention the lengthy and costly drug approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate effective formulation development approaches in order to improve bioavailability and therapeutic performance.

One strategy to improve API solubility is to reduce the API particle size to nano scale thus increasing the dissolution rate and bioavailability. Additionally, NETZSCH (a leader in grinding, micronization & dispersing as well as analyzing & testing) are sharing their recent article titled “Rapid development of API nano-formulations from screening to production combining dual centrifugation and wet agitator bead milling” which provides an in-depth, scientific and practical approach detailing nanoformulations and nanomilling as a platform for solving solubility issues.

2023 Global Drug Bioavailability Enhancement Summit

(May 16-17, 2023, Princeton, NJ)


Interested to improve the performance of your drug products? Learn 2 years of new drug product development approaches at the 2023 Summit this coming May both in-person & virtual.

Join 160+ leading drug delivery, formulation and development experts and hear 30+ expert sessions. Gain over 2 years worth of new drug product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 short days (all available on-demand)!

Save up-to 50% on attendance before Friday 28th October, 2022. Likewise, have a platform technology you would like to explore showcasing to the wider audience this May? Reach out below to find out remaining opportunities.

2021 On-Demand Summits Available for Purchase

(Limited time - Only $299)

Pin It on Pinterest

Share This

Share this with a friend or colleague!